-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : CANACCORD GENUITY CUTS TARGET PRICE TO $323 FROM $429

Reuters·10/30/2026 14:08:13